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Abstract
Decreased adipose tissue oxygen tension and increased HIF-1α expression can trigger adipose 
tissue inflammation and dysfunction in obesity. Our current understanding of obesity-associated 
decreased adipose tissue oxygen tension is mainly focused on changes in oxygen supply and 
angiogenesis. Here, we demonstrate that increased adipocyte O2 demand, mediated by ANT2 
activity, is the dominant cause of adipocyte hypoxia. Deletion of adipocyte Ant2 improves obesity-
induced intracellular adipocyte hypoxia by decreasing obesity-induced adipocyte oxygen demand, 
without effects on mitochondrial number or mass, or oligomycin-sensitive respiration. This led to 
decreased adipose tissue HIF-1α expression and inflammation with improved glucose tolerance 
and insulin resistance in both a preventative or therapeutic setting. Our results suggest that ANT2 
may be a target for the development of insulin sensitizing drugs and that ANT2 inhibition might 
have clinical utility.
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Introduction
Obesity is the most common cause of insulin resistance in man and the obesity epidemic is 
driving a parallel rise in the incidence of Type 2 diabetes mellitus (T2DM) 1. In obesity, the 
expanded adipose tissue depots exhibit altered glucose and lipid metabolic profiles, which 
contribute to systemic metabolic abnormalities 2. In addition to storing excess energy as 
triglycerides, adipose tissue plays an active role in maintaining systemic metabolic 
homeostasis through a multi-modular communication system with other tissues, including 
liver, skeletal muscle, pancreatic endocrine cells and brain 2,3. For example, adipocytes 
release multiple hormones and cytokines, including leptin, adiponectin and TNFα 4–6, as 
well as different lipid metabolite species including palmitoleate and conjugated fatty acids 
5,7
. These molecules can act in a paracrine and/or endocrine manner to regulate adipose 
tissue inflammatory tone and systemic energy balance and metabolism.
In obesity, macrophages and other immune cell types accumulate in adipose tissue 3,8. These 
immune cells release cytokines, chemokines and microRNA-containing exosomes which can 
gain access to the circulation and modulate systemic lipid and glucose homeostasis 9–11. 
Numerous in vitro and in vivo studies have demonstrated that genetic or pharmacologic 
inhibition of pro-inflammatory pathways in mice can block migration/accumulation of 
macrophages into adipose tissue with beneficial effects on glucose tolerance and systemic 
insulin sensitivity 3,12–16.
Recently, we 17 and others 18,19 have proposed that decreased adipose tissue oxygen (O2) 
tension and increased adipocyte hypoxia-inducible factor (HIF) −1α expression can be an 
initiating trigger for adipose tissue inflammation and dysfunction. During the course of high 
fat diet (HFD)/obesity, a decrease in intracellular adipocyte O2 tension with increased 
HIF-1α protein expression precedes macrophage accumulation and pro-inflammatory gene 
expression 17. HIF-1α is a ubiquitous transcription factor abundantly expressed in most cell 
types 20. In normoxic conditions, prolyl hydroxylase domain proteins (PHDs) bind to 
HIF-1α. PHD-dependent HIF-1α hydroxylation targets HIF-1α for ubiquitin-dependent 
proteasomal degradation. In hypoxic conditions, PHDs become inactive, leading to HIF-1α 
stabilization and increased expression of HIF-1α and its target genes involved in hypoxia 
responses, angiogenesis, macrophage chemotaxis and oxidative stress 20. Moreover, 
adipocyte-specific HIF-1α KO mice are protected from obesity-induced adipose tissue 
inflammation and systemic insulin resistance 17,21,22.
Tissue O2 tension is maintained by the balance between O2 demand and supply. Previous 
reports showed that O2 supply is compromised in obese adipose tissue (particularly in 
subcutaneous adipose tissue) and that diffusion of O2 to the cytosol might be limited by 
enlarging adipocyte size 23. While the effects of obesity on adipose tissue vascular function 
and O2 supply have been well studied 24, the impact of obesity on adipose tissue O2 demand 
is not clearly understood.
Recently, we proposed that increased intracellular saturated free fatty acid (FFA) levels 
stimulate an adenine nucleotide translocase (ANT)-2-dependent increase in uncoupled 
mitochondrial respiration 17. This leads to increased O2 consumption and a state of relative 
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adipocyte hypoxia with increased HIF-1α expression. In the current studies, we have 
generated adipocyte-specific ANT2 KO (ANT2 AKO) mice and assessed changes in O2 
balance, HIF-1α expression and inflammation within adipose tissue and adipocytes. We 
found that both decreased O2 supply and ANT2-mediated increased consumption contribute 
to decreased interstitial O2 tension in obese adipose tissue, but that increased O2 demand is 
the major determinant of intracellular hypoxia and increased HIF-1α expression.
Results
Generation of adipocyte-specific ANT2 KO mice
Previously we proposed that ANT2 mediates saturated fatty acid-induced increased 
uncoupled respiration, leading to relative hypoxia and increased HIF-1α expression in white 
adipocytes 17. To investigate the role of adipocyte ANT2 in obesity-induced adipose tissue 
hypoxia, inflammation and insulin resistance, we generated adipocyte-specific ANT2 
knockout (ANT2 AKO) mice using the Cre-loxP system (ANT2fl/fl:Adiponectin-Cre+/−). 
Cre− Ant2 floxed mice (ANT2fl/fl;Adiponectin-Cre−/−) were used as WT controls, referred 
to, hereafter, as WT. As expected, ANT2 mRNA expression was significantly diminished in 
epididymal (eWAT), inguinal (iWAT) and interscapular brown (BAT) adipose tissues of 
ANT2 AKO mice, compared with WT mice (Fig. 1a). Decreased Ant2 expression was 
restricted to adipocytes and Ant2 expression was not altered in stromal vascular cells (SVCs) 
of eWAT or in other tissues such as liver and muscle of ANT2 AKO mice, compared with 
WT mice (Fig. 1a,b). Ant1 mRNA expression was not changed in any of the tissues 
(including eWAT) and cell types examined in the ANT2 AKO mice.
Body weight and food intake were comparable in WT and ANT2 AKO mice on both normal 
chow diet (NCD) and high fat diet (HFD) (Fig. 1c,d and Supplementary Fig. 1). Physical 
activity and heat generation were also unaltered (Fig. 1e,f). The respiratory exchange ratio 
(RER) was slightly, but significantly elevated in ANT2 AKO mice, compared with WT 
controls (Fig. 1g), suggesting that the KO mice exhibit an increased preference for glucose 
over lipid as an energy source. Histologic analysis of epididymal adipose tissue revealed that 
deletion of Ant2 conferred increased adipocyte size by ~23% and a proportional increase in 
adipose tissue mass (Fig. 1h,i). Since the increases in adipocyte volume and adipose tissue 
mass were comparable, it is likely that ANT2 AKO does not change overall adipocyte 
number. This is shown by the corresponding decrease in small adipocytes and increase in 
larger ones (Fig. 1j).
Deletion of adipocyte Ant2 improves relative hypoxia and decreases HIF-1α expression
To assess the effect of adipocyte Ant2 deletion on adipose tissue O2 balance, we measured 
interstitial O2 tension and O2 supply in adipose tissue, along with O2 consumption in 
primary adipocytes. Consistent with previous reports 18,19, HFD/obesity decreased 
interstitial O2 tension in visceral adipose tissue in WT mice and Ant2 was abundantly 
expression in eWAT (Supplementary Fig. 2a,b). Interstitial O2 tension in eWAT, mesenteric 
WAT (mWAT) and iWAT was measured in individual mice on NCD and HFD, with 
consistent decreases noted in HFD vs NCD (Fig. 2a). eWAT Ant2 expression was unchanged 
in HFD WT compared with NCD WT mice (Supplementary Fig. 2b), consistent with the 
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view that increased ANT2 activity, but not expression, contributes to obesity-induced 
adipocyte oxygen consumption in obesity 17. The effect of obesity to decrease adipose O2 
tension was mitigated in AKO mice (Fig. 2a). This decrease in interstitial O2 tension in WT 
mice was not accompanied by decreased arterial O2 supply (Fig. 2b), but was associated 
with decreased functional capillary density (Fig. 2c) and increased adipocyte O2 
consumption (Fig. 2d). The relative intracellular hypoxic state was exemplified by increased 
pimonidazole adduct staining in HFD WT adipocytes compared with ANT2 KOs (Fig. 2e). 
Since pimonidazole forms protein adducts at O2 tensions below ~1.3%, these results suggest 
that the intracellular O2 concentration of adipocytes drops from the interstitial levels down to 
~1.3% or below.
In a general sense, HFD WT and AKO mice showed metabolic phenotypes similar to 
humans with metabolically-abnormal obesity (MAO) and metabolically-normal obesity 
(MNO), respectively. This prompted us to evaluate adipose tissue O2 tension in MNO and 
MAO in people. MNO and MAO were defined by the results of an oral glucose tolerance 
test and HbA1c values (Supplementary Table 1). Comparable to previous reports 25,26, 
adipose tissue interstitial O2 tension was generally 2-3 fold higher in humans than in mice 
(Fig. 2a,f). Interstitial adipose tissue O2 tension was lower in people with obesity than 
metabolically-normal lean participants (MNL) (Fig. 2f). Moreover, interstitial adipose tissue 
O2 tension was lower in MAO than MNO participants, and this is similar to the directional 
changes in comparative interstitial adipose tissue O2 tension values observed in WT and 
AKO HFD-fed mice (Fig. 2a,f).
To provide insight into the effects of O2 tension on HIF-1α expression, we incubated 3T3-
L1 adipocytes in O2 conditions ranging from 21% to 1%. Since eWAT interstitial oxygen 
levels were ~3.4% and 1.8% in lean and HFD/obese mice, respectively, we compared 
adipocyte HIF-1α expression at 2% and 3% O2. As seen in Fig. 2g and Supplementary Fig. 
2c, adipocyte HIF-1α expression was not increased at 2% O2 compared with 3% O2 , but 
was significantly increased at 1% O2.
In HFD WT mice, adipocyte O2 consumption is significantly increased compared with NCD 
mice 17 and deletion of ANT2 blocked this obesity-induced increase. This effect was 
preserved in the presence of the ATP synthase inhibitor (oligomycin), indicating that the 
decreased O2 consumption in HFD ANT2 KO adipocytes, compared with WT was largely 
due to decreased uncoupled respiration (Fig. 2d). Mitochondrial DNA content, citrate 
synthase activity and the levels of mitochondrial complex components were comparable in 
eWATs of HFD WT and ANT2 AKO mice (Supplementary Fig. 2d-f). Consistent with this, 
knockdown of ANT2 in 3T3-L1 adipocytes did not change citrate synthase activity or 
mitochondrial complex component expression (Supplementary Fig. 2g,h). Interestingly, the 
number of pimonidazole adduct-positive adipocytes was substantially decreased in eWAT of 
HFD ANT2 AKO mice compared with HFD WT controls without changes in O2 supply 
(Fig. 2b,e). Together, these results strongly suggest that relative intracellular hypoxia in 
obese adipocytes is due to ANT2-mediated increased uncoupled respiration and O2 
consumption and that interstitial O2 concentration can be dissociated from intracellular O2 
pressure in ANT2 AKO mice.
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We assessed whether the increased O2 tension in ANT2 KO adipocytes led to decreased 
HIF-1α expression, using Western blot analyses. On NCD, Hif1a mRNA and protein 
expression was comparable in WT and KO mice (Fig. 2h,i). However, on HFD, the 
expression of Hif1a protein and mRNA was significantly reduced in ANT2 AKO mice 
compared with WT mice (Fig. 2i,j). Clearly, the effects of the KO were greater on HIF-1α 
protein compared with mRNA expression, consistent with the well-known view that O2 
regulates HIF-1α mainly by affecting protein stability 27. Moreover, mRNA expression of 
HIF-1α target genes including Nos2, Cyr61 and Pdk1, which are increased in WT obese 
adipose tissue 17, were also decreased in the eWAT of HFD ANT2 AKO mice 
(Supplementary Fig. 2i).
ANT2 AKO mice display improved glucose tolerance and insulin sensitivity on HFD
To assess the metabolic consequence of adipocyte ANT2 KO, we measured glucose and 
insulin tolerance in WT and ANT2 AKO mice. On NCD, glucose tolerance and fasting 
plasma insulin levels were comparable in WT and ANT2 AKO mice (Fig. 3a,b). However, 
on HFD, ANT2 AKO mice exhibited significantly improved glucose tolerance with 
decreased fasting plasma insulin levels (Fig. 3c,d). Insulin tolerance was also substantially 
improved in HFD ANT2 AKO mice compared with WT controls (Fig. 3e). To quantitatively 
measure changes in insulin sensitivity in each of the classical insulin target tissues, liver, 
skeletal muscle and adipose tissue, we performed hyperinsulinemic euglycemic clamp 
studies. As seen in Fig. 3f, HFD ANT2 AKO mice displayed an ~39 % increase in systemic 
insulin sensitivity as assessed by the increased glucose infusion rate (GIR). This increase 
was mostly due to increased hepatic insulin sensitivity. Thus, insulin-dependent suppression 
of hepatic glucose production (HGP) was substantially increased in ANT2 AKO mice 
compared with WT controls (Fig. 3g,h). The ability of insulin to suppress plasma FFA levels 
provides an indication of adipose tissue insulin sensitivity, and the insulin-effect on plasma 
FFA suppression was also increased in ANT2 AKO mice compared with WT controls (Fig. 
3i and Supplementary Fig. 3a). On the other hand, insulin-stimulated glucose disposal rate 
(IS-GDR), which primarily reflects skeletal muscle insulin sensitivity, was not changed by 
adipocyte ANT2 KO (Fig. 3j). Consistent with this, insulin-stimulated Akt phosphorylation 
was markedly increased in eWAT and liver, but not muscle in HFD ANT2 AKO mice (Fig. 
3k). Together these results suggest that ANT2 AKO mice are protected from HFD-induced 
glucose intolerance and insulin resistance mainly through increased adipose tissue and liver 
insulin sensitivity.
Adiponectin is secreted specifically from adipocytes and enhances insulin sensitivity in liver 
and skeletal muscle, whereas pro-inflammatory cytokines induce insulin resistance 2. As 
seen in Fig. 3l, Adipoq mRNA levels were significantly increased in eWAT and primary 
adipocytes in ANT2 AKO mice. Moreover, serum and eWAT adiponectin protein levels was 
also increased in ANT2 AKO mice (Fig. 3m,n). Consistent with this, adiponectin expression 
was increased in ANT2 knockdown (KD) adipocytes (Supplementary Fig. 3b). In contrast, 
mRNA expression of pro-inflammatory cytokines such as Tnfa, Il6 and Pai1 was reduced in 
primary adipocytes or eWATs of ANT2 AKO mice with decreased plasma PAI-1 and MCP-1 
levels (Fig. 3o-q).
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ANT2 AKO mice are protected from HFD-induced adipose tissue inflammation and fibrosis
To investigate how deletion of adipocyte Ant2 led to decreased expression of pro-
inflammatory cytokines, we measured adipose tissue macrophage (ATM) accumulation. As 
seen in Fig. 4a, immuno-staining of adipose tissue sections with anti-F4/80 antibodies 
demonstrated decreased ATM content in eWAT from HFD ANT2 KO mice. Flow cytometry 
analysis of eWAT stromal vascular cells (SVCs) showed that the ratio of CD11b+ / F4/80+ 
double-positive ATMs was significantly decreased in HFD ANT2 AKO mice compared with 
HFD WT controls (Fig. 4b and Supplementary Fig. 4a), whereas, on NCD, ATM content 
was comparable in WT and ANT2 AKO mice (Supplementary Fig. 4b). Most of this change 
in ATM content was due to decreased CD11b+, F4/80+ and CD11c+ triple-positive M1-like 
polarized ATMs (Fig. 4c), with a smaller change in CD206+ M2-like polarized anti-
inflammatory ATMs (Supplementary Fig. 4c). This was accompanied by increased 
regulatory T cell (Treg) numbers in ANT2 AKO mouse adipose tissue (Fig. 4d and 
Supplementary Fig. 4d). Consistent with these results, we found decreased expression of 
macrophage genes such as Emr1 (coding F4/80), Cd11b and Cd11c in ANT2 AKO mouse 
adipose tissue, as well as decreased chemokine gene expression (Ccl2, Mip1a and Rantes) 
(Fig. 4e and Supplementary Fig. 4e).
Obesity can promote ATM accumulation by increasing blood monocyte recruitment into 
adipose tissue and by enhancing ATM proliferation 28,29. To test whether the decreased 
ATM accumulation and M1-like polarization in HFD ANT2 AKO mice involved decreased 
ATM proliferation, we analyzed the changes in Ki67+ proliferating ATMs in NCD and HFD 
WT and ANT2 AKO mice. Consistent with previous reports 29,30, a relatively modest 
(4-8%) proportion of ATMs were Ki67-positive and HFD increased the ratio of Ki67+ ATMs 
(Fig. 4f and Supplementary Fig. 4f), suggesting enhanced proliferation. However, ANT2 KO 
did not affect the HFD-induced Ki67+ ATM staining.
Next, we harvested conditioned media (CM) from differentiated 3T3-L1 adipocytes 
transfected with control or ANT2-specific siRNAs, and measured CM-induced chemotaxis 
of Raw264.7 monocytes/macrophages towards CM in Transwell dishes. As seen in Fig. 4g, 
migration of Raw267.4 was decreased with CM from ANT2 KD adipocytes. Consistent with 
this, the palmitate-induced increased expression of Ccl2 and Mip1a was lower in ANT2 KD 
adipocytes (Fig. 4h). ANT2 KD also decreased the expression of Il6 and Nos2 (Fig. 4h) with 
decreased reactive oxygen species (ROS) production (Supplementary Fig. 4g). Similarly, 
ANT2 KO in primary adipocytes decreased palmitate-induced Il6 and Nos2 expression 
(Supplementary Fig. 4h,i). Together, these results indicate that decreased adipocyte ANT2 
expression in HFD/obese mice lowers adipocyte expression of pro-inflammatory 
chemokines and cytokines, leading to decreased monocyte/macrophage infiltration, reducing 
the overall adipose tissue pro-inflammatory state.
HIF-1α can induce fibrogenic gene expression in adipose tissue, and fibrosis contributes to 
ectopic fat accumulation and exaggerates the ATM pro-inflammatory state 18. In line with 
this, incubation of adipocytes in hypoxic conditions increased fibrogenic gene expression 
and decreased the expression of genes involved in lipogenesis and mitochondrial oxidation 
(Supplementary Fig. 4j,k). Therefore, we assessed whether the decreased adipocyte HIF-1α 
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expression in ANT2 AKO mice also led to decreased adipose tissue fibrosis. Trichrome 
staining of eWAT sections revealed that ANT2 AKO mice were protected from HFD-
induced increased collagen fiber deposition in eWAT (Fig. 4i). Moreover, mRNA expression 
of Col1a1, Col3a1, Elastin, Lox and Fibronectin was decreased in eWAT and primary 
adipocytes of ANT2 AKO mice (Fig. 4j,k).
Inducible deletion of adipocyte Ant2 improves glucose and insulin tolerance in HFD mice
We questioned whether inhibition of ANT2 activity could also reverse established glucose 
intolerance and insulin resistance in obese insulin resistant mice. To address this question, 
we generated an inducible ANT2 AKO mouse strain (ANT2 iAKO) by crossing tamoxifen 
(Tam)-inducible Cre expressing transgenic mice to Ant2 floxed mice (Ant2fl/fl:Adiponectin-
CreERT2+/−). 12 week HFD insulin-resistant and glucose intolerant mice were given Tam 
treatment for 2 weeks. 1-2 week(s) after the final Tam injection, mice were subjected to 
glucose and insulin tolerance tests, and were sacrificed at 3 weeks for further tissue analysis 
(Fig. 5a). At sacrifice, total eWAT Ant2 mRNA expression level was reduced by 20% in total 
eWAT and 55% in isolated adipocytes without changes in body weight (Figs. 5b-d), As also 
seen in the constitutive ANT2 AKO mice, the decrease of Ant2 and the increase in Cre was 
limited to adipocytes, and were not observed in SVCs, liver, or skeletal muscle (Figs. 5b,c 
and Supplementary Fig. 5a,b). The proportion of pimonidazole adduct-positive hypoxic 
adipocytes and eWAT HIF-1α expression was markedly decreased in ANT2 iAKO mice 
(Fig. 5e,f). Moreover, glucose and insulin tolerance was significantly improved in Tam-
treated ANT2 iAKO mice compared with Tam-treated WT controls (Fig. 5g,h). Moreover, 
this acute deletion of adipocyte Ant2 led to reduced expression of a variety of macrophage 
and inflammatory marker genes in ANT2 KO eWAT compared with controls (Fig. 5i).
Adipocyte apoptosis is decreased in ANT2 AKO mice
To test whether deletion of adipocyte Ant2 reduces obesity-induced adipocyte death, we 
performed immunochemistry analysis of eWATs from HFD WT and ANT2 AKO mice. As 
seen in Fig. 6a, the number of cleaved (active form)-caspase-3 containing adipocytes was 
decreased in HFD ANT2 AKO mice. Consistent with this, cleaved caspase-3 protein levels 
and caspase-3/7 activity was also decreased in eWAT of HFD ANT2 KO mice compared 
with HFD WT controls (Fig. 6b,c). On the other hand, cathepsin D activity was unaltered in 
eWAT of ANT2 AKO mice (Fig. 6d). These results suggest that ANT2 AKO decreases 
adipocyte apoptosis, but not necrosis, in visceral adipose tissue.
To determine whether the decrease in adipocyte apoptosis is due to cell autonomous 
changes, we conducted in vitro ANT2 KD experiments. Chronic palmitate-induced 
increased caspase-3/7 activity was substantially reduced in ANT2 KD adipocytes (Fig. 6e). 
Moreover, chronic palmitate-induced decreased mitochondrial membrane potential (MMP) 
was reversed by ANT2 KD (Fig. 6f). We also measured palmitate-induced caspase-3/7 
activity in 3T3-L1 adipocytes transfected with anti-ANT2 siRNA, anti-HIF-1α siRNA or a 
constitutive active HIF-1α (CA-HIF-1α) expressing plasmid construct. As seen in Fig. 6g, 
overexpression of HIF-1α induced increased caspase-3/7 activity in adipocytes, which was 
not blocked by ANT2 KD, while the palmitate-induced increased caspase-3/7 activity was 
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blunted by HIF-1α KD. This suggest that palmitate-induced adipocyte apoptosis is mediated 
by an ANT2-dependent increase in HIF-1α expression.
Bcl-2/adenovirus E1B 19 KDa interacting protein 3 (BNIP3) is an atypical pro-apoptotic 
BH3-only protein localized to the mitochondria and mediates hypoxia-induced loss of 
mitochondrial potential and cell death 31–33. We hypothesized that the effect of palmitate 
treatment to induce adipocyte apoptosis could be mediated through HIF-1α-dependent 
induction of Bnip3 expression. Chronic palmitate treatment led to increased Bnip3 and 
HIF-1α mRNA expression, which was decreased by ANT2 or HIF-1α KD (Fig. 6h,i and 
Supplementary Fig. 6a,b). Moreover, eWAT Bnip3 expression was significantly decreased in 
HFD ANT2 AKO mice, compared with WT controls (Fig. 6j). To test whether Bnip3 is a 
direct target of HIF-1α, we measured HIF-1α occupancy on the Bnip3 promoter in 3T3-L1 
adipocytes incubated at normoxic (21% O2) vs hypoxic (1% O2) conditions, or after palmitic 
acid (PA) treatment with or without ANT2 KD. As seen in Figs. 6k,l, HIF-1α occupancy at 
the Bnip3 promoter was significantly increased by hypoxia or PA treatment. Moreover, the 
PA-induced increase in HIF-1α occupancy of the Bnip3 promoter was blocked by ANT2 
KD. These results suggest that increased HIF-1α contributes to obesity-induced adipocyte 
apoptosis by transactivating Bnip3 expression (Supplementary Fig. 6c).
PA can stimulate ceramide synthesis, and increased ceramides cause mitochondrial 
dysfunction/apoptosis 34. Furthermore, adiponectin expression was increased in ANT2 KD 
3T3-L1 adipocytes and in the plasma and eWAT of HFD ANT2 KO mice (Fig. 3l-n), and 
adiponectin stimulates ceramidase activity 35. We tested whether ceramides participate in 
PA/ANT2-mediated adipocyte death by measuring intracellular ceramide levels after acute 
(2min) or subchronic (3h) treatment with 400 μM PA. 3h treatment of 3T3-L1 adipocytes 
with PA increased intracellular ceramide levels, whereas, 2 min incubation did not (Fig. 6m). 
Since the maximal effects of FFA treatment to increase ANT2-dependent oxygen 
consumption occurs within 1-2 minute(s) (Supplementary Fig. 6d) 36, these results suggest 
that ceramides do not mediate the acute effects of FFAs to increase uncoupled mitochondrial 
respiration. Interestingly, the 3h PA-induced ceramide levels were attenuated in ANT2 KD 
cells (Fig. 6m). Therefore, it is likely that increased FFAs and inflammation along with 
decreased adiponectin expression can contribute to adipocyte apoptosis by increasing 
intracellular ceramide accumulation.
Discussion
In these studies, we demonstrate that deletion of adipocyte Ant2 improves adipose tissue 
inflammation and systemic insulin resistance, without changing body weight or energy 
expenditure in HFD/obese mice. Mechanistically, deletion of adipocyte Ant2 inhibited the 
obesity-induced increase in uncoupled respiration in white adipocytes, without affecting 
mitochondrial number, mass or electron transport chain component expression. This led to 
increased intra-adipocyte O2 tension and decreased HIF-1α expression. Consistent with this, 
mRNA expression of HIF-1α target genes that are typically increased in WT obese adipose 
tissue, was also decreased in the eWAT of HFD ANT2 AKO mice. This includes decreased 
expression of genes involved in macrophage chemotaxis, pro-inflammatory activation of 
macrophages, oxidative stress, cell death, and fibrosis. Accordingly, ATM accumulation and 
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M1-like polarization was reduced in ANT2 AKO mice along with decreased adipose tissue 
interstitial collagen deposition. Moreover, we found that deletion of adipocyte Ant2 
prevented obesity-induced adipocyte apoptosis with decreased pro-apoptotic Bnip3 
expression. Overall, these new results support the concept that obesity leads to increased 
adipocyte oxygen consumption causing a state of relative adipocyte hypoxia. This provides 
an early trigger for HIF-1α induction which promotes adipose tissue inflammation and 
systemic insulin resistance.
Tissue O2 tension is determined by the balance between O2 supply and demand. Several 
previous studies23,24 have shown decreased interstitial adipose tissue O2 tension in obesity 
with the general conclusion that this is due to a mechanical imbalance between capillary 
perfusion and the expanding adipocyte mass. However, in non-ischemic conditions, it is 
generally believed that increased O2 demand, instead of decreased O2 supply, is largely 
responsible for physiologic tissue hypoxia. Indeed, we have previously shown increased 
uncoupled respiration with increased adipocyte oxygen consumption in the initial stages of 
HFD/obesity 17. Our current in vivo studies of adipose tissue O2 kinetics, combined with ex 
vivo mitochondrial analyses and O2 consumption, shed new light on this issue. We show that 
ANT2 AKO selectively blocks the obesity-induced increased adipocyte O2 consumption, 
without changes in mitochondrial oxidative phosphorylation or systemic energy balance. 
This enabled us to use ANT2 AKO mice as a model system to analyze the relative 
contribution of increased O2 consumption to interstitial adipose tissue and intra-adipocyte 
O2 tension. Inhibition of obesity-induced O2 consumption in the AKO mice led to a ~35% 
increase in interstitial tissue oxygen tension, indicating that increased adipocyte O2 
consumption is responsible for a sizable component of the decrease in tissue O2 tension. 
Most likely, the decrease in functional capillary density contributes the additional 
component of decreased interstitial O2 tension. On the other hand, differences in 
intracellular adipocyte O2 consumption in vitro or in vivo were well-correlated to changes in 
intracellular O2 tension and HIF-1α expression. Taken together, these results suggest that 
decreased interstitial O2 tension in obesity is due to a combination of increased O2 demand 
and reduced supply. However, increased intracellular O2 consumption is the critical 
determinant of intracellular hypoxia, and is required for increased HIF-1α expression.
It is possible that the decreased interstitial O2 tension in chronic obesity creates a permissive 
environment allowing greater increases in HIF-1α expression. In this regard, it is important 
to note that inducible deletion of adipocyte Ant2 also exerted beneficial metabolic effects in 
the intervention mode. This indicates that ANT2-mediated increased O2 consumption plays 
a role in decreasing intracellular O2 tension, HIF-1α induction and increased inflammation 
in the context of chronic obesity. It is interesting to note that, in our inducible ANT2 KO 
mice, the KO efficiency was ~20% in whole adipose tissue and ~55% in adipocytes, while 
the beneficial metabolic effects were almost comparable to those in the constitutive ANT2 
AKO mice. This raises the possibility that adipocyte ANT2 is mediating a relatively rate-
limiting step to trigger adipose tissue inflammation, insulin resistance and glucose 
intolerance. Since pharmacologic intervention usually can not achieve 100% inhibition of a 
target, this also supports the idea that ANT2 could be a good target for anti-diabetic 
therapies.
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Obese subjects can be classified as MNO individuals, who exhibit normal glucose tolerance 
and insulin sensitivity with normal hepatic triglyceride levels or MAO, who are glucose 
intolerant, insulin resistant and have increased hepatic triglyceride content 37. While the 
mechanistic determinants between MNO and MAO individuals are still unclear and may be 
multifactorial, previous studies show that MNO subjects exhibit decreased adipose tissue 
inflammation along with an increased capacity to produce and accommodate intracellular 
lipids, compared with MAO individuals 37–39. In this study, we found that people with MAO 
had lower adipose tissue O2 tension than people with MNO, who in turn had lower adipose 
tissue O2 tension than MNL participants. This is directionally similar to the changes in 
interstitial O2 tension we observed in obese WT compared with obese AKO mice. A 
negative relationship between adipose tissue O2 tension and adipose tissue insulin sensitivity 
(insulin-mediated suppression of adipose tissue lipolysis) has been observed previously in 
people with obesity 40.
There are only a few examples of MNO-like animal models, without directly manipulating 
immune cell inflammatory pathways 41–43. While the molecular mechanisms through which 
each of the individual animal models acquire an MNO-like phenotype varies, all of these 
models exhibit a common metabolic adaptation to increased energy influx: with increased 
adipose tissue mass and decreased adipose tissue inflammation. With respect to the analogy 
between AKO mice and MNO subjects, we found that AKO mice display an overall increase 
in adipocyte size with an increase in the ratio of larger to smaller adipocytes, a finding also 
reported in MNO subjects 38. Further studies are required to determine whether decreased 
ANT2 activity is mechanistically related to the MNO phenotype in man.
It is of interest that the AKO mice showed a marked improvement in adipose tissue function 
and this was reflected by systemic insulin sensitivity in the liver, but not muscle. There are 
many other examples in which improved adipose tissue function causes increased insulin 
sensitivity in muscle and liver, but, in this case, the effects were hepatic restricted. The 
mechanism of this tissue-specific crosstalk between adipose tissue and liver remains to be 
defined.
We found that deletion of ANT2 prevented the adipocyte apoptosis associated with HFD in 
WT mice. Our results indicate that this was due to abrogation of HIF-1α induction in the 
AKO animals. This is consistent with the overall view that obesity induces adipocyte 
apoptosis, at least partially, through a cascade of events including ANT2 stimulation leading 
to HIF-1α induction with a subsequent HIF-1α-induced increase in Bnip3 expression. As an 
additional component, increased FFAs and inflammation, along with decreased adiponectin 
expression can chronically increase ceramide accumulation, providing a further mechanism 
to exaggerate adipocyte mitochondrial dysfunction and apopotosis. Additionally, our studies 
showed that the adipose tissue hypoxia in obesity is also downstream of intracellular 
adipocyte hypoxia.
There are 4 isoforms of ANTs in humans (ANT1, 2, 3 and 4) and 3 in mice (ANT1, 2 and 4) 
44
. In mouse adipocytes, ANT1 and 2 are predominantly expressed while ANT4 is barely 
detected 17. Only ANT2 mediates FFA-induced uncoupled respiration while ANT1 is 
responsible for the basal respiratory activity of mitochondria 17,45. In this study, we observed 
Seo et al. Page 10
Nat Metab. Author manuscript; available in PMC 2019 September 16.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
that adipocyte ANT2 KO did not affect ANT1 expression in fat cells. While redundant and 
distinct roles and expression patterns of different ANT isoforms in adenine nucleotide 
transport across the mitochondrial inner membrane have been reported, the molecular 
mechanisms of how different ANT isoforms exert their effects remain to be determined.
In this study, we demonstrate that deletion of adipocyte Ant2 in obese mice improved 
glucose intolerance and insulin resistance by decreasing obesity-induced uncoupled 
respiration, O2 consumption and HIF-1α expression in adipocytes. These beneficial effects 
were seen in both prevention and intervention modes. Other studies have shown that liver-
specific ANT2 KO protects mice from HFD-induced liver steatosis 46. Taken together, these 
results suggest a plausible scenario in obesity-induced inflammation and insulin resistance. 
Thus, obesity leads to a rapid initial onset of increased uncoupled respiration in adipocytes 
via an ANT2-mediated mechanism. This results in: increased adipocyte O2 consumption → 
relative adipocyte hypoxia → increased HIF-1α expression → increased adipose tissue 
inflammation → systemic insulin resistance. This suggests that ANT2 may be an important 
insulin sensitizing drug discovery target, and future work will be necessary to determine 
whether this has clinical utility.
Online Methods
Animals
To generate adipocyte-specific ANT2 KO mice, Ant2fl/fl mice 47 were crossed to mice 
expressing Cre recombinase (Jackson Labs, strain # 028020) or Cre-ERT2 chimeric protein 
(Jackson Labs, strain # 025124) under the control of the Adiponectin promoter. Mice were 
housed in colony cages in 12 h light/12 h dark cycles. For the HFD study, 8 week-old male 
mice were subjected to 60% HFD for the indicated time periods (Research Diets, Inc). 
Glucose and insulin tolerance tests and hyperinsulinemic-euglycemic clamp experiments 
were performed as described previously 16,17. Briefly, for euglycemic clamp studies, mice 
were surgerized for jugular vein cannulation. After five days of recovery, mice were fasted 
for 6 h and infused with D-[3-3H] glucose (Perkin Elmer) for 90 min. After tracer 
equilibration, blood samples were collected at −10 and 0 min (basal). Glucose (50% 
dextrose) and tracer (5 uCi/h) plus insulin (8 mU/kg/min) were then infused into the jugular 
vein. Blood glucose levels were monitored at every 10 min and glucose infusion rate was 
adjusted as necessary. Steady-state blood glucose levels were maintained at 120 mg/dl ± 10 
mg/dl for the last 20 min or longer, without changing glucose infusion rate, and blood 
samples were collected at 110 and 120 min (clamped). Specific activity and plasma free fatty 
acid and insulin levels were measured from the basal and clamped plasma samples. 
Metabolic rate and physical activity were measured monitored with the CLAMS/Oxymax 
system (Columbus Instruments). All animal procedures were performed in accordance with 
an IACUC-approved protocol and the research guidelines for the use of laboratory animals 
of University of California San Diego.
Study subjects
Twenty seven men and women participated in this study. Subjects were characterized by 
body weight status and metabolic health into three groups: 1) metabolically-normal lean 
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(MNL; n=7) defined as body mass index (BMI) 18.5–24.9 kg/m2, fasting plasma glucose 
concentration <100 mg/dl, 2-hr oral glucose tolerance test (OGTT) plasma glucose 
concentration <130 mg/dl, and hemoglobin A1c ≤5.5%; 2) metabolically-normal obese 
(MNO; n=11) defined as BMI ≥30.0 kg/m2, fasting plasma glucose concentration <100 
mg/dl, 2-hr OGTT plasma glucose concentration <130 mg/dl, and hemoglobin A1c ≤5.5%; 
and 3) metabolically abnormal obese (MAO; n=9), defined as BMI ≥30.0 kg/m2, fasting 
plasma glucose concentration ≥100 mg/dl, or 2-hr OGTT plasma glucose concentration 
≥140 mg/dl, or hemoglobin A1c 5.7–6.4%. This study was approved by the Institutional 
Review Board of Washington University School of Medicine in St. Louis, MO; written 
informed consent was obtained from all subjects before their participation 
(ClinicalTrials.gov, NCT02706262).
Adipose tissue pO2 measurements in human Subjects
All procedures were performed in the Clinical Research Unit. Body fat mass was determined 
by dual energy x-ray absorptiometry. An OGTT was performed in the morning after subjects 
fasted for 12 h overnight. Blood samples were obtained through an indwelling intravenous 
line before and 120 min after subjects ingested a 75 g glucose drink to determine plasma 
glucose concentrations. On a separate occasion, subcutaneous abdominal adipose tissue O2 
tension (pO2) was determined. After subjects fasted for 12 hr overnight, the periumbilical 
area of the abdomen was cleaned and draped, the skin anesthetized with 1% lidocaine, and a 
small 0.5 cm skin incision was made under sterile conditions. A sterile 250 um diameter, O2-
sensitive fiber-optic probe (OxyLite™, Oxford Optronix, Ltd. Milton Park, Abingdon, 
United Kingdom) was inserted through the skin incision into subcutaneous abdominal 
adipose tissue and held in place for two minutes. Data were recorded every 10 seconds and 
the pO2 value for each subject was calculated as the average of all values obtained during 
steady-state (defined as less than a 10% variance in pO2 for at least 40 seconds).
Interstitial O2 tension in mice
The O2 partial pressure was measured using carbon fiber electrodes (Carbostar-1, Kation 
Scientific; Minneapolis, MN). The tip of the electrode was coated with 5% Nafion (Sigma; 
St. Louis, MO) to increase O2 specificity. The process consisted of three individual Nafion 
coats. The microelectrodes were polarized at −0.8 V relative to a silver-silver chloride 
reference electrode (Cypress Systems; Lawrence, KS). O2 measurements were performed 
using the two electrodes system (working and reference electrode), and the current generated 
was measured with a potentiostat and electrometer (Keithley model 610C; Cleveland, OH). 
The microelectrodes were calibrated at 37°C with 0, 5, 10 and 21% O2 gases (Airgas; Los 
Angeles, CA), and tissues were superfused (0.1 mL/min) with physiological Krebs salt 
solution. The tissue was maintained at 35–37°C by the heated Krebs solution. The solution 
was spread on the tissue as a thin film, drained into a platter, and drawn off by suction. The 
solution was equilibrated with 95% N2 and 5% CO2, which maintained the superfusate at a 
pH of 7.4 and minimized O2 delivery to the tissue from the atmosphere. O2 measurements 
were made by penetrating the tissue with the microelectrode tip. The reference electrode was 
placed in the bath, and the microelectrode was placed in a shielded holder and advanced 
towards the measurement site with a micromanipulator. A long-working distance ×10 Leitz 
objective was used to direct the electrode to the measurement site. Before measurements, the 
Seo et al. Page 12
Nat Metab. Author manuscript; available in PMC 2019 September 16.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
electrode tip was immersed in the supernatant suffusion solution and the current was 
registered. The supernatant suffusion solution was set as 0 mmHg reference point. Upon 
introduction into the tissue, the microelectrodes responded with a time constant that was 
estimated to be of the order of 10 sec. A stable reading was obtained within 30 sec, and upon 
reaching the current plateau value, the electrode was extracted from the tissue and the tip 
maintained within the suffusing saline solution. The unit of tissue O2 tension was converted 
from mmHg to %, later.
Functional capillary density
Functional capillary density (FCD) was defined as the ratio of the total length of capillary 
segments with transit of, at least, a single RBC in a 60-s period per total length of plasma-
perfused capillary segements. This parameter was evaluated in 20 successive microscopic 
fields (totaling a region of ~1.6 mm2, 420 × 320 μm each) by systematically displacing the 
microscopic field of view by a field width in successive steps in the lateral direction. The 
first field was chosen by a distinctive anatomic landmark (i.e., large microvascular 
bifurcation) to easily and quickly re-establish the same observation fields at each 
observation time point. Each field had between 10 and 18 capillary segments with RBC 
flow. Total length of the RBC-perfused capillaries per the given microscopic field area of 
view, was evaluated by measuring and adding the length of capillaries with RBC transit in 
the field of view for 60s.
Adipocyte O2 consumption rate
O2 consumption in primary adipocytes were measured as described previously 17.
Histology
Immunohistochemistry analyses were performed as described previously 17. For apoptotic 
cells analysis, paraffin-embedded tissue sections were stained with anti-Perilipin (Abcam, 
Cat. No. ab-61682) and cleaved caspase-3 (Cell Signaling Technology, Cat No. 9664) 
antibodies. Images were captured using a NanoZoomer slide scanner system with 
NanoZoomer Digital Pathology software (Hamamatsu) or confocal fluorescence microscopy. 
Microscopic images were analyzed using ImageJ software.
Western blot analysis
Tissues and cells were lysed with Mammalian Protein Extraction Reagent (Thermo 
Scientific, Rockford, IL) containing EDTA-free protease and phosphatase inhibitor mixture 
(Roche Diagnostics) and then centrifuged at 12,000 rpm for 10 min at 4 °C. The 
supernatants were separated by precast gels (Bio-Rad) using a running buffer and 
electrotransferred to polyvinylidene difluoride (PVDF) membranes. The membranes were 
blocked for 2 h in Tris-buffered saline with Tween 20 (TBST) (10 mM Tris-HCl, 0.1% 
Tween 20, pH 7.4) containing 5% BSA and then incubated with anti-cleaved caspase-3 (Cell 
signaling technology, Cat. No. 9664), HIF-1α (Abcam, Cat. No. ab-2185), HIF-2α (Novus 
Biologicals, Cat. No. NB100-122), HSP90 (Santa Cruz Biotechnology, Cat. No. SC-13119), 
total OXPHOS rodent WB antibody cocktail (Abcam, ab-110413), Adiponectin (Invitrogen, 
Cat No. MA1-054) antibodies at 4 °C for overnight. After washing with fresh TBST, the 
Seo et al. Page 13
Nat Metab. Author manuscript; available in PMC 2019 September 16.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
membrane was incubated with secondary antibody conjugated with horseradish peroxidase 
specific to rabbit or mouse IgG (Jackson ImmunoResearch Lab.; 1:5,000 dilution) and 
visualized using the ECL system (Thermo Scientific) followed by autoradiography or Bio-
Rad ChemiDoc XRS+ imaging system. Intensity of the bands in the autoradiograms was 
measured using ImageJ software.
Quantitative real-time PCR
Total RNA was extracted by TRIzol reagent (Invitrogen) or RNeasy Mini Kit (QIAGEN, 
Hilden, Germany). Synthesis of cDNA was performed using the High-Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, Foster City, CA). Quantitative real-time 
PCR (qRT-PCR) was performed using Power SYBR Green PCR Master Mix (Applied 
Biosystems) and primers shown in Supplementary Table 2.
Mitochondrial DNA content
Total DNA was extracted from cells using the DNeasy Blood & Tissue Kit (Qiagen 
Technologies, USA) according to the instructions from the manufacturer. The relative 
mtDNA copy number was determined by normalizing mtDNA copy number to genomic 
GAPDH copy number (Quispe-Tintaya et al. 2013). Primer sequences are shown in 
Supplementary Table 2.
Mitochondrial citrate synthase activity
Citrate synthase activities were measured using a commercial kit according to the 
manufacturer’s instruction (BioVision, Milpitas, CA, USA).
Insulin-stimulated AKT phosphorylation in mouse tissues
In vivo tissue insulin action was evaluated by measuring insulin-stimulated Akt 
phosphorylation in liver, skeletal muscle, and eWAT. Briefly, after 6 hr fasting, mice were 
anesthetized and parts of these insulin target tissues were collected to measure basal level of 
Akt phosphorylation. After a dose of insulin (0.6 U/kg body weight) was injected via 
inferior vena cava, parts of liver, skeletal muscle, and eWAT were collected at 3 min, 7 min, 
and 10 min, respectively. Total and phospho-Akt levels were measured by Western blot 
analyses. Phosphorylated Akt (Ser473, Cat. No. 4060) or total AKT (Cat. No. 4685) was 
purchased from Cell Signaling Technology, Inc.
Serum/plasma insulin and adipokine measurements
Serum/plasma adipokine and insulin levels were measured by using multiplex mouse 
adipokine assays (EMD Millipore) or insulin ELISA (ALPCO) kit.
Adipose tissue fractionation and flow cytometry
Flow cytometry analysis of adipose tissue immune cells was performed as described 
previously 16,17. Briefly, epididymal adipose tissues were minced and digested with 
collagenase (1 mg/mL; Sigma-Aldrich) buffer for 30 min at 37°C with shaking. The digests 
were filtered through 100 μm cell strainers and centrifuged at 500 g for 5 min. Pellets 
containing SVCs were saved for immune cell analysis. After incubation in erythrocyte lysis 
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buffer (eBioscience) for 5 min, cells were resuspended into FACS buffer (PBS supplemented 
with 1% endotoxin-low BSA). Cells were stained with Live/Dead Aqua to exclude dead 
cells and blocked with CD16/32 monoclonal antibody (Thermofisher, Cat No. 14-0161-81). 
The fluorescence labeled antibodies against CD45 (eBioscience, Cat No. 83-0451-42) for 
leukocytes, CD11b (eBioscience, Cat No. 11-0112-82), F4/80 (eBioscience, Cat No. 
25-4801-82), CD11c (eBioscience, Cat No. 17-0114-82), and CD206 (BioLegend, Cat No. 
141706) for macrophages, CD3 (eBioscience, Cat No. 56-0032-82), CD4 (eBioscience, Cat 
No. 17-0041-82), CD8 (BioLegend, Cat No. 100722), and Foxp3 (eBioscience, Cat No. 
12-5773-80) for T cells were used. For intracellular staining of Foxp3, we used Foxp3 
staining kits (eBioscience, Cat No. 00-5523-00) according to the manufacturer’s 
instructions. For the assessment of proliferating ATMS, FITC-labeled Ki-67 monoclonal 
antibodies (eBioscience, Cat. No. 11-5698-82) were used. Cells were gently washed twice 
and resuspended in FACS buffer. Data was acquired in a FACS CANTO (BD Biosciences) 
and analyzed using FlowJo software (Treestar).
Cell culture and adenovirus infection
3T3-L1 preadipocytes were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS), at 10% CO2 and 37°C. Differentiation of 
3T3-L1 cells was induced as described previously 48. Briefly, confluent cells were incubated 
for 2 days in a medium comprising DMEM supplemented with 10% FBS, 0.5 mM 3-
isobutyl-1-methylxanthine, 1 μM dexamethasone, and 10 μg of insulin/ml. Thereafter, 
medium was replaced every other day with DMEM containing 10% FBS and 10 μg/ml 
insulin.
Primary preadipocytes were isolated from subcutaneous adipose tissue of ANT2fl/fl mice 
using a conventional collagenase method. Differentiated adipocytes were infected with 
adenovirus (Ad-mock and Ad-Cre-GFP) 12 h after plating for 24 h at multiplicity of 
infection (m.o.i.) of 100 in serum-free medium. After 24 h, cells were stimulated with 
palmitic acid for 48 h. RNA was extracted and qRT-PCR was performed as described above.
siRNAs and transient transfection
The negative control (sc-37007) and specific siRNAs against ANT2 (sc-72506), and HIF-1α 
(sc-35562) were purchased from Santa Cruz Biotechnology, Inc. Transfections were 
performed with DharmaFECT 1 transfection reagent (Dharmacon) and conducted according 
to the manufacturer’s instruction.
Measurement of intracellular ROS and mitochondrial membrane potential (MMP)
Intracellular ROS and MMP levels were measured using 5-(and-6)-chloromethyl-2′,7′-
dichlorodihydro-fluorescein diacetate (CM-H2DCF-DA; Molecular Probes, Eugene, OR, 
USA) and 1 μM tetramethylrhodamine, ethyl ester (TMRE, Life Technologies), respectively.
Caspase-3/7 activity and viable cell activity assays
Caspase-3/7 activity and viable cell activity were measured by using ApoLive-Glo™ 
Multiplex Assay kit (Promega, USA).
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Chromatin Immunoprecipitation (ChIP) Assays
ChIP was performed using the ChIP-IT High Sensitivity Kit (Active Motif, Cat. No. 5030) 
according to the manufacturer’s instructions, with minor modifications. Differentiated 3T3-
L1 adipocytes were cross-linked with 1% formaldehyde, followed by quenching with 135 
mM glycine. Cells were disrupted with a Dounce homogenizer and the chromatin was 
isolated. The lysates were sonicated to shear the DNA to an average length of 300–600 bp. 
Chromatin was immunoprecipitated using an anti-HIF1α (Abcam, Cat. No. ab-2185) 
antibody or nonspecific rabbit IgG control (Jackson ImmunoResearch Laboratories, 
011-000-003). ChIP DNAs were purified and ChIP enrichment was quantified by 
quantitative PCR (qPCR). Fold enrichment was determined by the fold input method. 
Primers used were for Bnip3-HRE (forward, 5’-CGG TCC ACT TCT GCA TTA GA-3’ and 
reverse, 5’-CAC TGG ACT GAG GGA CAA GG-3’) as described previously 49.
Ceramide Measurement
At the end of treatment, 3T3-L1 adipocytes (in 6-well plates) were washed with ice-cold 
PBS and saved at −70°C. For ceramide assays, adipocytes were scrapped off in 0.5 ml 
methanol and transferred to 2ml Eppendorf tubes. 1ml of 50% chloroform was added to each 
tube and the vortexed. After centrifugation at 10,000g for 10 minutes. Two fluid layers were 
generated, separated by a white protein-containing interphase. The upper aqueous layers 
were discarded, and lower organic layers were transferred into new Eppendorf tubes. The 
interphase was saved for protein assays. Organic solvent was dried by blowing nitrogen gas. 
To the dry tubes, 100 μl reaction buffer (RB) containing 0.15% Triton X-100, 0.2 mM 
cardiolipin in 20 mM Hepes, 10 mM KCl, 15 mM MgCl2 and 1 mM DTT was added. The 
tubes containing lipids in RB were subjected to sonication in ice to form lipid micelles. 
These micelles were analyzed for ceramide content. We adopted a protocol from Don AS 
and Rosen H (Analytical Biochemistry, vol. 375, p.265-271, 2008). The principle of the 
assay was to convert ceramide to ceramide phosphate in presence of a ceramide kinase 
preparation (Sigma) and γ32P-ATP (Perkin Elmer). The reaction mixture contained 0.1 μCi 
γ32P-ATP (5 mM) per assay and incubated at 35°C for 30 minutes. Reactions were stopped 
by adding 250 μl of a mixture of chloroform and methanol (2:1). The reaction tubes were 
centrifuged (10000 μ g for 10 minutes) to separate two layers and subsequently, ceramides 
and ceramide phosphates present in the lower organic phase were separated by thin layer 
chromatography (TLC) on silica gel 60 plates (Millipore) using a solvent mixture, n-butanol: 
acetic acid: water (3:1:1) to achieve the separation. At first, we calibrated the assay using 
fluorescent labeled C8-NBD-Ceramide (Cayman Chemicals) as the substrate to visualize the 
formation of C8-NBD-Ceramide-32P-phosphates on the TLC plate. A calibration curve 
consisting of n moles of NBD-ceramide used as substrate versus the radioactive counts on 
the fluorescent spots on the TLC plates was constructed. It is to be noted that the aqueous 
phase demonstrated no significant fluorescent spots. Although aqueous phase had all the 
residual unreacted γ32p-ATP, there was no significant radioactivity on the designated TLC 
spots for NBD-Ceramide-phosphates (visualized by running reference NBD-Ceramide-
phosphates during TLC analysis of the aqueous phase). Therefore, while assaying the 
micelles prepared from 3T3-L1 extracts, we decided to directly count radioactivity in the 
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organic phase and determine n moles of ceramide present from the calibration curve. The 
ceramide content of 3T3-L1 adipocytes were normalized to protein content.
Statistics
The results are shown as means ± SEM. Statistical analyses were performed by the two-
tailed Student’s t test (for comparison between two groups) or 1 or 2-way ANOVA (for 
comparison between three or more groups or in two groups at multiple time points, 
respectively, with post-hoc t tests between the individual groups) unless indicated in the 
figure legend; p < 0.05 was considered significant. Statistical methods were not used to 
predetermine necessary sample size, but sample sizes were chosen based on estimates from 
pilot experiments and previously published results such that appropriate statistical tests 
could yield significant results. Statistical analyses used in the data presented are justified and 
described in all legends. Parametric tests were used that assume normal distribution, which 
we showed to be the case when data were plotted as frequencies. Variances were tested by 
Levene’s test for homogeneity of variance, and variances in the data were not significantly 
different.
Life Sciences Reporting Summary
Further information on experimental design is available in the Life Sciences Reporting 
Summary.
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All data that support the findings of this study are included in the paper or its supplementary 
information.
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Figure 1. 
Adipocyte-specific ANT2 knockout mice exhibit normal body weight with increased 
adipose tissue mass. (a) mRNA expression of ANT1 and ANT2 in different tissues of WT 
and ANT2 AKO mice fed HFD for 12 weeks (n=6 mice per group). *P=0.00038, 
**P=0.0062, and ***P=0.0056 vs. WT controls. (b) mRNA expression of ANT1 and ANT2 
in primary adipocytes (n=14 mice per group) and SVCs (n=8 mice per group) isolated from 
eWAT of WT and ANT2 AKO mice. *P=8.25×10−17, vs. WT controls. (c) Body weight gain 
on HFD (n=17 and 22 for WT and AKO mice, respectively). (d) Average daily food intake 
in HFD WT (n=5 mice) and ANT2 AKO mice (n=6 mice). (e-g) Metabolic rates (heat 
generation, e; locomotor activity, f; respiratory exchange rate, g) of HFD WT and ANT2 
AKO mice (n=6 mice per group). Each of data points from individual mice was omitted in 
the bar graph to more clearly show the mean values and error bar sizes. Statistical analyses 
were performed by the two-way ANOVA. (h) Tissue weights of eWAT of HFD WT (n=13) 
and ANT2 AKO (n=18) mice. (i) H&E staining (left) of eWAT and the frequency 
distribution of adipocyte sizes (middle) and average adipocyte volume (right). n=8 (7944 
cells) and 6 (4334 cells) mice for WT and AKO, respectively. Scale bar, 200 μm. *P=0.0064, 
** P=0.0022, *** P=0.018, and #P=0.010 vs WT controls. Box plot element and lines 
indicate the range of minimum to maximum and curve fits, respectively. (j) The frequency 
distribution in panel i was divided into tertiles and the right hand bars show he ratio of 
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lowest and highest adipocyte size tertiles. Statistical analyses in panels a,b,h-j were 
performed by the two-tailed Student’s t test. All data are presented as mean +/− SEM.
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Figure 2. 
Intracellular O2 tension and HIF-1α expression are decreased in the eWAT of ANT2 AKO 
mice. (a,b) Interstitial O2 tension (a) and arterial O2 supply (b) in the eWAT of NCD or 
HFD WT or ANT2 AKO mice (n=4, 6, 8 (or 4) and 4 mice, respectively). **P=0.0041, 
ξξξP=5.1×10−6, ***P=4.3×10−7 according to the two-way ANOVA with post-hoc two-tailed 
t-tests between the individual groups. #P=0.073 (one-tailed t-test). (c) Functional capillary 
density in eWAT of mice fed NCD or HFD (n=4 mice per group). *P=0.0015, **P=0.0024, 
ξP=3.0×10−5, and ξξP=2.1×10−5. (d) O2 consumption in primary adipocyte isolated from 
eWAT of mice fed HFD WT or AKO mice (n=5 and 6 mice for HFD WT and HFD AKO, 
respectively). NCD WT mouse data was modified from a previous report 17. *P=0.0074, 
**P=0.011. (e) Pimonidazole (brown) and H&E stainings of eWAT from WT (n=6 mice) 
and ANT2 AKO (n=7 mice) mice fed NCD or HFD. Scale bar, 200 μm. P=0.037. (f) Human 
subcutaneous abdominal adipose tissue O2 tension. Subcutaneous abdominal adipose tissue 
O2 tension in metabolically-normal lean (MNL) (n=7 individual participants), metabolically-
normal obese (MNO) (n=11 individual participants) and metabolically-abnormal obese 
(MAO) (n=9 individual participants) participants. *P=0.01, ξP=0.028. (g) Western blot 
analysis of HIF-1α protein expression at different O2 conditions. (h-j) Protein (h, j) and 
mRNA (i) levels of HIF-1α in eWAT of NCD (h, i) or HFD (i, j) WT or ANT2 AKO mice. 
Individual data points in panels h,i,j were collected from 2 WT and 2 KO mice (h), 7 NCD 
WT, 5NCD KO, 8 HFD WT and HFD KO mice (i), and 8 WT and 8 KO mice (j), 
respectively. *P=0.012, #P=0.045 according to the two-tailed t-test. Similar results to those 
in panels g,h data were obtained from at least two independent experiments. All data are 
presented as mean +/− SEM. Statistical analyses in panels c-f were performed by the 
ANOVA with post-hoc two-tailed t-tests between the individual groups.
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Figure 3. 
ANT2 AKO mice are protected from HFD-induced adipose tissue inflammation, glucose 
intolerance and insulin resistance. (a) GTTs in NCD mice (WT, n=10; ANT2 AKO, n=5). 
(b) Fasting plasma insulin levels in NCD mice (n=11 and 6 mice for WT and ANT2 AKO, 
respectively). (c) GTTs in 12 week HFD mice (n=11 and 8 mice for WT and ANT2 AKO, 
respectively). aP=0.008, bP=0.043, cP=0.028, according to the two-way ANOVA with post-
hoc two-tailed t-tests between the individual groups. (d) Fasting plasma insulin levels in 
HFD mice (n=8 and 11 mice for WT and ANT2 AKO, respectively). (e) ITTs in HFD mice 
for 12 weeks (n=8 and 11 mice for WT and ANT2 AKO, respectively). aP=0.020, bP=0.002, 
cP=0.030, dP=0.005, eP=0.005 according to the two-way ANOVA with post-hoc two-tailed t-
tests between the individual groups. (f-j) Systemic and tissue-specific effects of ANT2 AKO 
was determined by hyperinsulinemic euglycemic clamp studies in 12 week HFD mice (n=4 
and 6 mice for WT and ANT2 AKO, respectively). (f) GIR. (g) HGP. (h) HGP suppression. 
(i) Suppression of plasma FFA levels. (j) IS-GDR. (k) Akt phosphorylation in eWAT, liver, 
and muscle of WT and ANT2 AKO mice. Representative data from two independent 
experiments are shown. (l) mRNA levels of adiponectin in eWAT and primary adipocytes of 
HFD WT and ANT2 AKO mice (n=8 mice per group). *P=0.027, ξP=0.018. (m,n) Western 
blot analysis of adiponectin protein levels in eWAT (m; n=12 mice per group) and serum (n; 
n=10 and 11 for WT and AKO, respectively) of HFD WT and ANT2 AKO. Representative 
images were shown on the top of each bar graph. (o,p) mRNA levels of inflammatory 
cytokines in primary adipocytes (o) or eWAT (p) of HFD WT (n=16 mice) and ANT2 AKO 
(n=10 mice per group) mice. (q) Serum levels of PAI-1 and MCP-1 in HFD WT (n=11 mice) 
and ANT2 AKO mice (n=15 mice). Statistical analyses in panels d,f-i,l-q were performed by 
the two-tailed Student’s t test. All data are presented as mean +/− SEM.
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Figure 4. 
HFD-induced ATM accumulation and M1-like polarization is reduced in ANT2 AKO mice 
with improved adipose tissue fibrosis. (a) F4/80 staining (brown) of eWAT sections of 12 
week HFD mice (n=9 and 5 mice for WT and AKO, respectively). Scale bar, 200 μm. (b-d) 
Flow cytometry analysis of eWAT SVCs of 12 week HFD mice (n=8). Total macrophage 
(CD45+ / CD11b+ / F4/80+ triple positive cells) (b), CD11c+ M1-like polarized macrophage 
(c), and Treg (CD3+ / CD4+ / Foxp3+ triple positive cells) (d) ratio among total SVC 
population was calculated and presented in bar graphs. Representative scatter plot images 
were shown on the left side of each bar graph or in Supplementary Fig. 4d. (e) mRNA levels 
of macrophage marker and chemokine genes in eWAT of HFD WT and ANT2 AKO mice 
were measured by qRT-PCR (n=16 and 10 for WT and ANT2 AKO mice, respectively). (f) 
The ratio of Ki67+ ATM population in ATMs of NCD WT, HFD WT, or HFD ANT2 AKO 
mice (n=6 mice per group). **P=0.0020. N.S., not significant. (g) Migration of Raw264.7 
macrophage cells to ACM harvested from 3T3-L1 cells transfected with control or anti-
ANT2 siRNA (n=4 wells per group). ***P=0.0007, ##P=0.0043. (h) mRNA levels of 
inflammatory gene expression. 3T3-L1 adipocytes were transfected with control or ANT2 
siRNAs and then incubated in no or high palmitic acid (400 μM) medium for 24 h (n=4 
wells per group). For MCP1, ***P=9.8×10−5, ** P=0.0050, ##P=0.0034. For MIP1α, ** 
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P=0.0023, ##P=0.0060. For IL-6, **P=1.5×10−5, *** P=1.3×10−5, ###P=4.4×10−7. For 
iNOS, ** P=0.0022, *** P=0.00029, ##P=1.6×10−6. (i) Trichrome (blue) staining of eWAT 
sections of 12 week HFD mice (n=9 and 6 mice for WT and AKO, respectively). Scale bar, 
200 μm. (j,k) mRNA levels of fibrogenic genes in primary adipocytes (j) and eWAT (k) of 
HFD mice (n=16 and 10 mice for WT and AKO, respectively). Statistical analyses in panels 
a-e,i-k were performed by the two-tailed Student’s t test. Statistical analyses in panels f-h 
were performed by the ANOVA with post-hoc two-tailed t-tests between the individual 
groups. All data are presented as mean +/− SEM.
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Figure 5. 
Inducible ANT2 AKO reverses established glucose and insulin intolerance. (a) Schematic 
representation of the experimental scheme for tamoxifen injection and metabolic analyses in 
inducible adipocyte ANT2 AKO mice. (b) mRNA levels of Ant2 and Ant1 in eWATs of WT 
and KO mice after induction (n=9 and 5 mice for WT and AKO, respectively). *P=0.037. (c) 
mRNA levels of Ant2, and Ant1 in adipocyte and SVC fraction of eWATs of WT and KO 
mice after induction (n=10 and 8 mice for WT and AKO, respectively). ***P=0.0058. (d) 
Body weight of HFD WT and KO at 22 weeks of age (n=10 and 6 mice for WT and AKO, 
respectively). (e) Ratio of pimonidazole adduct positive area among total section area (n=8 
and 7 mice per group). Scale bar, 200 μm. (f) Western blot analysis of HIF-1α expression in 
HFD WT and ANT2 iAKO mice (n=4 mice per group). (g) GTTs (n=7 mice per group). 
aP=0.018, bP=0.045, cP=0.005, dP=0.004. (h) ITTs (n=10 and 6 mice for WT and AKO, 
respectively). aP=0.024, bP=0.015, and cP=0.014. (i) mRNA levels of inflammatory genes in 
eWAT (n=9 and 5 mice for WT and AKO, respectively). Statistical analyses were performed 
by the two-tailed Student’s t test (in panels b,c,e,f,i) or by the two-way ANOVA with post-
hoc two-tailed t-tests between the individual groups (in panels g,h). All data are presented as 
mean +/− SEM.
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Figure 6. 
HFD-induced adipocyte apoptosis is decreased in ANT2 AKO mice. (a) Immunofluoresence 
staining of eWATs from 12 week HFD mice. Percentage of cleaved caspase-positive area 
was calculated and graphed on the right (n=8 mice per group). Scale bar, 200 μm. (b) 
Cleaved caspase-3 protein levels in eWAT of 12 week HFD mice (n=8 mice per group). (c) 
Caspase-3/7 activity in eWAT and iWAT of HFD WT (n=12 mice) and KO (n=8 mice) mice. 
(d) Cathepin D activity in eWAT (n=5, 2, 11 and 8 mice in bars 1 through 4) . (e,f) ANT2 
effects on adipocyte apoptosis. 24 h after siRNA transfection, cells were incubated with or 
without high palmitate (PA; 400 μM) for 24 h, and subjected to caspase-3/7 activity (e; 
**P=0.0062, #P=0.012, ξP=0.014) or MMP (f; ***P=0.00083, *P=0.010) measurements 
(n=4 wells per group). (g) Chronic palmitate-induced Caspase-3/7 activity in 3T3-L1 
adipocytes with ANT2 KD, HIF-1α KD and/or constitutively active (CA)-HIF-1α 
overexpression (n=9, 8,6,7,11,12,6,5,4, and 4 wells in bars 1 through 10). aP=0.013, 
bP=0.0067, cP=0.0021, dP=0.016, and eP=0.00066 vs lane 1; fP=0.030, and gP=0.039 vs lane 
2. (h) Bnip3 mRNA expression in the same set of samples in panel e. *P=0.045, #P=0.038. 
(i) mRNA levels of Bnip3 in control or HIF-1α KD adipocytes (n=6 wells per group). 
***P=0.00014, *P=0.0054, ##P=0.0054. (j) mRNA levels of Bnip3 in eWAT of HFD WT 
(n=16 mice) and KO mice (n=10 mice). (k,l) ChIP analysis of HIF-1α occupancy at Bnip3 
promoter in 3T3-L1 adipocytes incubated at normoxic (21% O2) or hypoxic (1% O2) 
condition for 3h (k), or after 400 μM palmitic acid treatment for 24h (l). n=6 wells per 
group. *P=0.021, **P=0.0028. (m) Intracellular ceramide levels in control or ANT2 KD 
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3T3-L1 adipocytes. 48h after siRNA transfection, cells were incubated with or without 400 
μM palmitate-containing media for 2 min or 3h, and subjected to intracellular ceramide 
measurements (n=4 wells per group). **P=0.012, #P=0.045. Statistical analyses were 
performed by the two-tailed Student’s t test (in panels a-c,j,l,m(left)) or by the ANOVA with 
post-hoc two-tailed t-tests between the individual groups was performed (in panels e-
i,m(left)). All data are presented as mean +/− SEM.
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